Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-09-10
1986-03-25
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514218, 544284, 544291, 2602433, A61K 31505, C07D40314
Patent
active
045783896
ABSTRACT:
The invention relates to quinazoline derivatives corresponding to the following general formula ##STR1## in which R is a mono- to trisubstituted 5-ring heterocycle from the group comprising triazoles, oxadiazoles, thiazoles and imidazoles, the heterocycle being attached to the piperazine or homopiperazine ring by a carbon atom, and n has a value of 2 or 3, or R represents an N-cyanophenyl imidocarbonate group, and to physiologically compatible salts thereof, to processes for their production and to medicaments containing these compounds.
REFERENCES:
patent: 4351832 (1982-09-01), Rakhitg et al.
patent: 4377581 (1983-03-01), Hess et al.
Ahrens Kurt H.
Morsdorf Peter
Schickaneder Helmut
Szeleny Istvan
Hollrah Glennon H.
Ludwig Heumann & Co. GmbH
Turnipseed James H.
LandOfFree
Quinazoline and medicaments containing these compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline and medicaments containing these compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline and medicaments containing these compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-631019